Bioptik Technology (4161) - Total Liabilities

Latest as of December 2025: NT$597.14 Million TWD ≈ $18.81 Million USD

Based on the latest financial reports, Bioptik Technology (4161) has total liabilities worth NT$597.14 Million TWD (≈ $18.81 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore Bioptik Technology (4161) equity growth momentum to track the company's year-over-year net asset growth rate.

Bioptik Technology - Total Liabilities Trend (2017–2025)

This chart illustrates how Bioptik Technology's total liabilities have evolved over time, based on quarterly financial data. See cash generation quality of Bioptik Technology to measure how efficiently the company converts operating cash flow to free cash.

Bioptik Technology Competitors by Total Liabilities

The table below lists competitors of Bioptik Technology ranked by their total liabilities.

Company	Country	Total Liabilities
Poh Huat Resources Holdings KLSE:7088	Malaysia	RM69.16 Million
Better Life Group Co Ltd TW:1805	Taiwan	NT$352.66 Million
Biokarpet S.A. AT:BIOKA	Greece	€145.70 Million
eHealth Inc NASDAQ:EHTH	USA	$231.46 Million
Pembangunan Jaya Ancol Tbk JK:PJAA	Indonesia	Rp1.70 Trillion
K Seng Seng Corporation Bhd KLSE:5192	Malaysia	RM133.85 Million
Tidehold Development Co Ltd TW:9902	Taiwan	NT$86.81 Million
Alpha Holdings Inc KQ:117670	Korea	₩15.32 Billion

Liability Composition Analysis (2017–2025)

This chart breaks down Bioptik Technology's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see market value of Bioptik Technology.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	1.93	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.62	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.38	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Bioptik Technology's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Bioptik Technology (2017–2025)

The table below shows the annual total liabilities of Bioptik Technology from 2017 to 2025.

Year	Total Liabilities	Change
2025-12-31	NT$597.14 Million ≈ $18.81 Million	+2.52%
2024-12-31	NT$582.47 Million ≈ $18.35 Million	-13.52%
2023-12-31	NT$673.56 Million ≈ $21.22 Million	-15.53%
2022-12-31	NT$797.40 Million ≈ $25.12 Million	-3.86%
2021-12-31	NT$829.38 Million ≈ $26.13 Million	+12.37%
2020-12-31	NT$738.10 Million ≈ $23.25 Million	-6.10%
2019-12-31	NT$786.05 Million ≈ $24.76 Million	-0.76%
2018-12-31	NT$792.07 Million ≈ $24.95 Million	+16.81%
2017-12-31	NT$678.08 Million ≈ $21.36 Million	--

About Bioptik Technology

TWO:4161 Taiwan Medical Devices

Market Cap

$42.21 Million

NT$1.34 Billion TWD

Market Cap Rank

#22471 Global

#1388 in Taiwan

Share Price

NT$22.40

Change (1 day)

+1.82%

52-Week Range

NT$21.60 - NT$31.35

All Time High

NT$69.78